YGX-1

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameYGX-1
Drug Alias NameYGX-1YGX1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYoungene Therapeutics Inc Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYoungene Therapeutics Inc Ltd
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A